A discussion on adult mesenchymal stem cells for drug delivery: pros and cons

Therapeutic Delivery Review by Lauren S Sherman, Alexandra Condé-Green, Oleta A Sandiford & Pranela Rameshwar (New Jersey Medical School, Newark, NJ, USA) discussing drug delivery by MSCs, looking at the benefits of MSCs and discuss challenges that require further scientific exploration for MSCs to successfully be used to deliver pharmacological agents and regenerate tissues.

Go to the profile of RegMedNet
Aug 05, 2016
0
0
Upvote 0 Comment

Mesenchymal stem cells (MSCs) are emerging as candidates for acting directly as therapeutics, as well as indirectly as delivery agents for other therapeutics, thanks to characteristics such as their ease of isolation and homing abilities. This Review by Lauren S Sherman, Alexandra Condé-Green, Oleta A Sandiford & Pranela Rameshwar (New Jersey Medical School, Newark, NJ, USA) discusses the advantages of MSCs as therapeutic agents and roadbloacks that require further scientific exploration.

Lauren S Sherman, Alexandra Condé-Green, Oleta A Sandiford, Pranela Rameshwar. A discussion on adult mesenchymal stem cells for drug delivery: pros and cons. Thera. Deliv. 6(12), 1335–1346 (2016).

Go to the profile of RegMedNet

RegMedNet

eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.